<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.jnrbm.com/feeds/latestarticles/journal?quantity=&amp;format=rss&amp;version=">
        <title>Journal of Negative Results in BioMedicine - Latest Articles</title>
        <link>http://www.jnrbm.com</link>
        <description>The latest research articles published by Journal of Negative Results in BioMedicine</description>
        <dc:date>2009-12-15T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/8/1/12" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/8/1/11" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/8/1/10" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/8/1/9" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/8/1/8" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/8/1/7" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/8/1/6" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/8/1/5" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/8/1/4" />
                                <rdf:li rdf:resource="http://www.jnrbm.com/content/8/1/3" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.jnrbm.com/content/8/1/12">
        <title>PALB2 variants in hereditary and unselected Finnish Prostate cancer cases </title>
        <description>Background:
PALB2 1592delT mutation is associated with increased breast cancer and suggestive prostate cancer (PRCA) risk in Finland. In this study we wanted to assess if any other PALB2 variants associate to increased PRCA risk and clinically describe patients with formerly found PALB2 1592delT mutation.
Methods:
Finnish families with two or more PRCA cases (n = 178) and unselected cases (n = 285) with complete clinical data were initially screened for variants in the coding region and splice sites of PALB2. Potentially interesting variants were verified in additional set of unselected cases (n = 463).
Results:
From our clinically defined sample set we identified total of six variants in PALB2. No novel variants among Finnish PRCA cases were found. Clinical characteristics of the variant carriers, including the previously described family carrying PALB2 1592delT, revealed a trend towards aggressive disease, which also applied to a few non-familial cases. Hypersensitivity to mitomycin C (MMC) of lymphoblasts from individuals from the family with 1592delT revealed haploinsufficiency among carriers with altered genotype.
Conclusions:
Though any of the detected PALB2 variants do not associate to PRCA in population level in Finland it cannot be ruled out that some of these variants contribute to cancer susceptibility at individual level.</description>
        <link>http://www.jnrbm.com/content/8/1/12</link>
                <dc:creator>Sanna Pakkanen</dc:creator>
                <dc:creator>Tiina Wahlfors</dc:creator>
                <dc:creator>Sanna Siltanen</dc:creator>
                <dc:creator>Mimmi Patrikainen</dc:creator>
                <dc:creator>Mika Matikainen</dc:creator>
                <dc:creator>Teuvo Tammela</dc:creator>
                <dc:creator>Johanna Schleutker</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2009, 8:12</dc:source>
        <dc:date>2009-12-15T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-8-12</dc:identifier>
        <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>8</prism:volume>
        <prism:startingPage>12</prism:startingPage>
        <prism:publicationDate>2009-12-15T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/8/1/11">
        <title>Human spongiosa mesenchymal stem cells fail to generate cardiomyocytes in vitro</title>
        <description>Background:
Human mesenchymal stem cells (hMSCs) are broadly discussed as a promising cell population amongst others for regenerative therapy of ischemic heart disease and its consequences. Although cardiac-specific differentiation of hMSCs was reported in several in vitro studies, these results were sometimes controversial and not reproducible.
Results:
In our study we have analyzed different published protocols of cardiac differentiation of hMSCs and their modifications, including the use of differentiation cocktails, different biomaterial scaffolds, co-culture techniques, and two- and three-dimensional cultures. We also studied whether 5&apos;-azacytidin and trichostatin A treatments in combination with the techniques mentioned above can increase the cardiomyogenic potential of hMSCs. We found that hMSCs failed to generate functionally active cardiomyocytes in vitro, although part of the cells demonstrated increased levels of cardiac-specific gene expression when treated with differentiation factors, chemical substances, or co-cultured with native cardiomyocytes.
Conclusion:
The failure of hMSCs to form cardiomyocytes makes doubtful the possibility of their use for mechanical reparation of the heart muscle.</description>
        <link>http://www.jnrbm.com/content/8/1/11</link>
                <dc:creator>Svetlana Mastitskaya</dc:creator>
                <dc:creator>Bernd Denecke</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2009, 8:11</dc:source>
        <dc:date>2009-11-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-8-11</dc:identifier>
        <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>8</prism:volume>
        <prism:startingPage>11</prism:startingPage>
        <prism:publicationDate>2009-11-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/8/1/10">
        <title>Lack of association between mutations of gene encoding mitochondrial D310 (displacement loop) mononucleotide repeat and oxidative stress in chronic dialysis patients in Taiwan</title>
        <description>Background:
Mitochondria (mt) are highly susceptible to reactive oxygen species (ROS). In this study, we investigated the association between a region within the displacement loop (D-loop) in mtDNA that is highly susceptible to ROS and oxidative stress markers in chronic dialysis patients. We enrolled 184 chronic dialysis patients and 213 age-matched healthy subjects for comparison. Blood levels of oxidative stress markers, such as thiobarbituric acid reactive substances (TBARS) and free thiol, and the mtDNA copy number were determined. A mononucleotide repeat sequence (CCCC...CCCTCCCCCC) between nucleotides 303 and 316-318 (D310) was identified in mtDNA.
Results:
Depending on alterations in the D310 mononucleotide repeat, subjects were categorized into 4 subgroups: 7-C, 8-C, 9 or 10-C, and T-to-C transition. Oxidative stress was higher in chronic dialysis patients, evidenced by higher levels of TBARS and mtDNA copy number, and a lower level of free thiol. The distribution of 7-C, 8-C, and 9-10C in dialysis and control subjects was as follows: 7-C (38% vs. 31.5%), 8-C (35.3% vs. 43.2%), and 9-10C (24.5% vs. 22.1%). Although there were significant differences in levels of TBARS, free thiol, and the mtDNA copy number in the D310 repeat subgroups (except T-to-C transition) between dialysis patients and control subjects, post hoc analyses within the same study cohort revealed no significant differences.
Conclusion:
Although oxidative stress was elevated in chronic dialysis patients and resulted in a compensatory increase in the mtDNA copy number, homopolymeric C repeats in the mtDNA region (D310), susceptible to ROS, were not associated with oxidative stress markers in these patients.</description>
        <link>http://www.jnrbm.com/content/8/1/10</link>
                <dc:creator>Jin-Bor Chen</dc:creator>
                <dc:creator>Tsu-Kung Lin</dc:creator>
                <dc:creator>Shang-Chih Liao</dc:creator>
                <dc:creator>Wen-Chin Lee</dc:creator>
                <dc:creator>Lung-Chih Lee</dc:creator>
                <dc:creator>Chia-Wei Liou</dc:creator>
                <dc:creator>Pei-Wen Wang</dc:creator>
                <dc:creator>Mao-Meng Tiao</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2009, 8:10</dc:source>
        <dc:date>2009-11-05T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-8-10</dc:identifier>
        <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>8</prism:volume>
        <prism:startingPage>10</prism:startingPage>
        <prism:publicationDate>2009-11-05T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/8/1/9">
        <title>Expression of estrogen and progesterone receptors in vestibular schwannomas and their clinical significance</title>
        <description>ObjectiveThe objective was to determine the expression of estrogen and progesterone receptors in vestibular schwannomas as well as to determine predictive factors for estrogen and progesterone receptor positivity.Materials and methodsThe study included 100 cases of vestibular schwannomas operated from January 2006 to June 2009. The clinical details were noted from the medical case files. Formaldehyde-fixed parafiin-embedded archival vestibular schwannomas specimens were used for the immunohistochemical assessment of estrogen and progesterone receptors.
Results:
Neither estrogen nor progesterone receptors could be detected in any of our cases by means of well known immunohistochemical method using well documented monoclonal antibodies. In the control specimens, a strongly positive reaction could be seen.
Conclusion:
No estrogen and progesterone receptor could be found in any of our 100 cases of vestibular schwannomas. Hence our study does not support a causative role of estrogen and progesterone in the growth of vestibular schwannoma as well as hormonal manipulation in the treatment of this tumor.</description>
        <link>http://www.jnrbm.com/content/8/1/9</link>
                <dc:creator>Sushila Jaiswal</dc:creator>
                <dc:creator>Vinita Agrawal</dc:creator>
                <dc:creator>Awadhesh Jaiswal</dc:creator>
                <dc:creator>Rakesh Pandey</dc:creator>
                <dc:creator>Ashok Mahapatra</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2009, 8:9</dc:source>
        <dc:date>2009-11-04T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-8-9</dc:identifier>
        <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>8</prism:volume>
        <prism:startingPage>9</prism:startingPage>
        <prism:publicationDate>2009-11-04T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/8/1/8">
        <title>Refractoriness of hepatitis C virus internal ribosome entry site to processing by Dicer in vivo</title>
        <description>Background:
Hepatitis C virus (HCV) is a positive-strand RNA virus harboring a highly structured internal ribosome entry site (IRES) in the 5&apos; nontranslated region of its genome. Important for initiating translation of viral RNAs into proteins, the HCV IRES is composed of RNA structures reminiscent of microRNA precursors that may be targeted by the host RNA silencing machinery.
Results:
We report that HCV IRES can be recognized and processed into small RNAs by the human ribonuclease Dicer in vitro. Furthermore, we identify domains II, III and VI of HCV IRES as potential substrates for Dicer in vitro. However, maintenance of the functional integrity of the HCV IRES in response to Dicer overexpression suggests that the structure of the HCV IRES abrogates its processing by Dicer in vivo.
Conclusion:
Our results suggest that the HCV IRES may have evolved to adopt a structure or a cellular context that is refractory to Dicer processing, which may contribute to viral escape of the host RNA silencing machinery.</description>
        <link>http://www.jnrbm.com/content/8/1/8</link>
                <dc:creator>Dominique Ouellet</dc:creator>
                <dc:creator>Isabelle Plante</dc:creator>
                <dc:creator>Vincent Boissonneault</dc:creator>
                <dc:creator>Cherifa Ayari</dc:creator>
                <dc:creator>Patrick Provost</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2009, 8:8</dc:source>
        <dc:date>2009-08-13T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-8-8</dc:identifier>
        <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>8</prism:volume>
        <prism:startingPage>8</prism:startingPage>
        <prism:publicationDate>2009-08-13T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/8/1/7">
        <title>Divine intervention? A Cochrane review on intercessory prayer gone beyond science and reason</title>
        <description>We discuss in this commentary a recent Cochrane review of 10 randomised trials aimed at testing the religious belief that praying to a god can help those who are prayed for. The review concluded that the available studies merit additional research. However, the review presented a scientifically unsound mixture of theological and scientific arguments, and two of the included trials that had a large impact on the findings had problems that were not described in the review. The review fails to live up to the high standards required for Cochrane reviews.</description>
        <link>http://www.jnrbm.com/content/8/1/7</link>
                <dc:creator>Karsten Juhl Jorgensen</dc:creator>
                <dc:creator>Asbjorn Hrobjartsson</dc:creator>
                <dc:creator>Peter Gotzsche</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2009, 8:7</dc:source>
        <dc:date>2009-06-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-8-7</dc:identifier>
        <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>8</prism:volume>
        <prism:startingPage>7</prism:startingPage>
        <prism:publicationDate>2009-06-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/8/1/6">
        <title>Number of teeth and myocardial infarction and stroke among elderly never smokers</title>
        <description>Background:
In most previous studies the association between number of teeth and cardiovascular diseases has been found to be stronger among younger age groups than in older age groups, which indicates that age may modify the association between number of teeth and cardiovascular diseases.We investigated the association between tooth loss and atherosclerotic vascular diseases such as myocardial infarction and stroke in a homogeneous elderly population.The study population was comprised of a subpopulation of 392 community-living elderly people who participated in the population-based Kuopio 75+ study. The data were collected through an interview, a structured clinical health examination and from patient records. The main outcome measures were a history of diagnosed myocardial infarction and diagnosed ischemic stroke. Prevalence proportion ratios (PPR) were estimated using generalised linear models.
Results:
Edentate subjects had a weakly, statistically non-significantly increased likelihood of a history of myocardial infarction and ischemic stroke compared with dentate subjects. Those with a large number of teeth had a slightly, but not statistically significantly increased likelihood of a history of myocardial infarction and ischemic stroke compared with those with a small number of teeth.
Conclusion:
These data did not show evidence that total or partial tooth loss would be associated with atherosclerotic vascular diseases such as myocardial infarction and ischemic stroke among an elderly population aged 75 years or older.</description>
        <link>http://www.jnrbm.com/content/8/1/6</link>
                <dc:creator>Anna-Maija Syrjala</dc:creator>
                <dc:creator>Pekka Ylostalo</dc:creator>
                <dc:creator>Sirpa Hartikainen</dc:creator>
                <dc:creator>Raimo Sulkava</dc:creator>
                <dc:creator>Matti Knuuttila</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2009, 8:6</dc:source>
        <dc:date>2009-04-22T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-8-6</dc:identifier>
        <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>8</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2009-04-22T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/8/1/5">
        <title>Effects of lead exposure on hippocampal metabotropic glutamate receptor subtype 3 and 7 in developmental rats</title>
        <description>Background:
A complete explanation of the mechanisms by which Pb2+ exerts toxic effects on developmental central nervous system remains unknown. Glutamate is critical to the developing brain through various subtypes of ionotropic or metabotropic glutamate receptors (mGluRs). Ionotropic N-methyl-D-aspartate receptors have been considered as a principal target in lead-induced neurotoxicity. The relationship between mGluR3/mGluR7 and synaptic plasticity had been verified by many recent studies. The present study aimed to examine the role of mGluR3/mGluR7 in lead-induced neurotoxicity.
Methods:
Twenty-four adult and female rats were randomly selected and placed on control or 0.2% lead acetate during gestation and lactation. Blood lead and hippocampal lead levels of pups were analyzed at weaning to evaluate the actual lead content at the end of the exposure. Impairments of short -term memory and long-term memory of pups were assessed by tests using Morris water maze and by detection of hippocampal ultrastructural alterations on electron microscopy. The impact of lead exposure on mGluR3 and mGluR7 mRNA expression in hippocampal tissue of pups were investigated by quantitative real-time polymerase chain reaction and its potential role in lead neurotoxicity were discussed.
Results:
Lead levels of blood and hippocampi in the lead-exposed rats were significantly higher than those in the controls (P &lt; 0.001). In tests using Morris Water Maze, the overall decrease in goal latency and swimming distance was taken to indicate that controls had shorter latencies and distance than lead-exposed rats (P = 0.001 and P &lt; 0.001 by repeated-measures analysis of variance). On transmission electron microscopy neuronal ultrastructural alterations were observed and the results of real-time polymerase chain reaction showed that exposure to 0.2% lead acetate did not substantially change gene expression of mGluR3 and mGluR7 mRNA compared with controls.
Conclusion:
Exposure to lead before and after birth can damage short-term and long-term memory ability of young rats and hippocampal ultrastructure. However, the current study does not provide evidence that the expression of rat hippocampal mGluR3 and mGluR7 can be altered by systemic administration of lead during gestation and lactation, which are informative for the field of lead-induced developmental neurotoxicity noting that it seems not to be worthwhile to include mGluR3 and mGluR7 in future studies.</description>
        <link>http://www.jnrbm.com/content/8/1/5</link>
                <dc:creator>Jian Xu</dc:creator>
                <dc:creator>Huai Yan</dc:creator>
                <dc:creator>Bo Yang</dc:creator>
                <dc:creator>Lu Tong</dc:creator>
                <dc:creator>Yu Zou</dc:creator>
                <dc:creator>Ying Tian</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2009, 8:5</dc:source>
        <dc:date>2009-04-20T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-8-5</dc:identifier>
        <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>8</prism:volume>
        <prism:startingPage>5</prism:startingPage>
        <prism:publicationDate>2009-04-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/8/1/4">
        <title>Comparison between the HCV IRES domain IV RNA structure and the Iron Responsive Element</title>
        <description>Background:
Serum ferritin and hepatic iron concentrations are frequently elevated in patients who are chronically infected with the hepatitis C virus (HCV), and hepatic iron concentration has been used to predict response to interferon therapy, but these correlations are not well understood. The HCV genome contains an RNA structure resembling an iron responsive element (IRE) in its internal ribosome entry site (IRES) structural domain IV (dIV). An IRE is a stem loop structure used to control the expression of eukaryotic proteins involved in iron homeostasis by either inhibiting ribosomal binding or protecting the mRNA from nuclease degradation. The HCV structure, located within the binding site of the 40S ribosomal subunit, might function as an authentic IRE or by an IRE-like mechanism.
Results:
Electrophoretic mobility shift assays showed that the HCV IRES domain IV structure does not interact with the iron regulatory protein 1 (IRP1) in vitro. Systematic HCV IRES RNA mutagenesis suggested that IRP1 cannot accommodate the shape of the wild type HCV IRES dIV RNA structure.
Conclusion:
The HCV IRES dIV RNA structure is not an authentic IRE. The possibility that this RNA structure is responsible for the observed correlations between intracellular iron concentration and HCV infection parameters through an IRE-like mechanism in response to some other cellular signal remains to be tested.</description>
        <link>http://www.jnrbm.com/content/8/1/4</link>
                <dc:creator>Ebenezer Tumban</dc:creator>
                <dc:creator>Jenna Painter</dc:creator>
                <dc:creator>William Lott</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2009, 8:4</dc:source>
        <dc:date>2009-02-18T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-8-4</dc:identifier>
        <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>8</prism:volume>
        <prism:startingPage>4</prism:startingPage>
        <prism:publicationDate>2009-02-18T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnrbm.com/content/8/1/3">
        <title>Evaluation of vardenafil for the treatment of subjective tinnitus: a controlled pilot study</title>
        <description>Background:
Vardenafil (Levitra&#174;) represents a potent and highly selective phosphodiesterase type 5 (PDE5) inhibitor, which is established for treatment of various diseases. There are several unpublished reports from patients stating that vardenafil has a considerable therapeutic effect on their concomitant tinnitus. This pilot study was conducted to specifically assess the effect of vardenafil in patients with chronic tinnitus.
Methods:
This trial was based on a prospective, randomized, double-blind, placebo-controlled, parallel group design. Fourty-two consecutive subjects with mon- or binaural chronic tinnitus received 10 mg vardenafil (N = 21) or matching placebo tablets (N = 21) administered orally twice a day over a period of 12 weeks. Clinical examination and data acquisition took place at each visit: at baseline, after 4 weeks, after 12 weeks (end of treatment with study medication), and at non-medicated follow-up after 16 weeks. Assessment of clinical effectiveness was based on a standardized tinnitus questionnaire (TQ), the Short Form 36 health survey (SF-36), audiometric measurements (mode, pitch and loudness of tinnitus; auditory thresholds) and biomarkers of oxidative stress in patients&apos; blood (malondialdehyde, protein carbonyl, homocysteine and total antioxidative status). Therapeutic efficacy was evaluated by comparison of subjective and objective parameters with baseline data between both treatment groups (ANCOVA).
Results:
Vardenafil had no superior efficacy over placebo in the treatment of chronic tinnitus during this study. The primary efficacy criterion &apos;TQ total score&apos; failed to demonstrate significant improvement compared to placebo. Subjective reports of TQ subscales and general quality of life areas (SF-36), objective audiometric examinations as well as investigated biomarkers for oxidative stress did not reveal any significant treatment effects. The safety profile was favorable and consistent with that in other vardenafil studies.
Conclusion:
Although hypoxia and ischemia play a special role in the pathogenesis of tinnitus, the PDE5-inhibitor-induced increase of nitric oxide-mediated vasodilatation exerted no specific influence on tinnitus symptomatology. Considering the unclear risk of rarely associated hearing impairment, systemic application of vardenafil or other PDE5 inhibitors prove to be not appropriate for therapy of chronic tinnitus.</description>
        <link>http://www.jnrbm.com/content/8/1/3</link>
                <dc:creator>Birgit Mazurek</dc:creator>
                <dc:creator>Heidemarie Haupt</dc:creator>
                <dc:creator>Agnieszka Szczepek</dc:creator>
                <dc:creator>Joerg Sandmann</dc:creator>
                <dc:creator>Johann Gross</dc:creator>
                <dc:creator>Burghard Klapp</dc:creator>
                <dc:creator>Holger Kiesewetter</dc:creator>
                <dc:creator>Ulrich Kalus</dc:creator>
                <dc:creator>Timo Stover</dc:creator>
                <dc:creator>Philipp Caffier</dc:creator>
                <dc:source>Journal of Negative Results in BioMedicine 2009, 8:3</dc:source>
        <dc:date>2009-02-17T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-5751-8-3</dc:identifier>
        <prism:publicationName>Journal of Negative Results in BioMedicine</prism:publicationName>
        <prism:issn>1477-5751</prism:issn>
        <prism:volume>8</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2009-02-17T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
